scholarly article | Q13442814 |
P356 | DOI | 10.1002/DVDY.10365 |
P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fdvdy.10365 |
https://onlinelibrary.wiley.com/doi/full/10.1002/dvdy.10365 | ||
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/dvdy.10365 | ||
P698 | PubMed publication ID | 14517991 |
P5875 | ResearchGate publication ID | 238274219 |
P2093 | author name string | J. Zhang | |
T. Williams | |||
P2860 | cites work | Transcription factor gene AP-2 gamma essential for early murine development | Q24537286 |
Transcriptional activation by Myc is under negative control by the transcription factor AP-2 | Q24568331 | ||
AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis | Q62818027 | ||
Evidence of a locus for orofacial clefting on human chromosome 6p24 and STS content map of the region | Q72144569 | ||
Drosophila transcription factor AP-2 in proboscis, leg and brain central complex development | Q113266266 | ||
The genomic structure of the human AP-2 transcription factor | Q24611259 | ||
Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control | Q28141560 | ||
Cloning and characterization of the mouse AP-2 epsilon gene: a novel family member expressed in the developing olfactory bulb | Q28506443 | ||
Absence of radius and ulna in mice lacking hoxa-11 andhoxd-11 | Q28509169 | ||
Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties | Q28510687 | ||
Transcription factor AP-2 essential for cranial closure and craniofacial development | Q28513302 | ||
Requirement for AP-2alpha in cardiac outflow tract morphogenesis | Q28584763 | ||
AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice | Q28586197 | ||
AP-2alpha transcription factor is required for early morphogenesis of the lens vesicle | Q28587027 | ||
Transcription factor activator protein-2 is required for continued luteinizing hormone-releasing hormone expression in the forebrain of developing mice | Q28590484 | ||
Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta | Q28591284 | ||
Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2 | Q28594321 | ||
Keratin 10 gene expression during differentiation of mouse epidermis requires transcription factors C/EBP and AP-2 | Q28594699 | ||
Simplified mammalian DNA isolation procedure | Q29618648 | ||
Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis | Q33515610 | ||
Evidence for positive and negative regulation of the Hox-3.1 gene | Q33872699 | ||
Retinoids in embryonal development | Q33967658 | ||
Cloning and characterization of a novel human transcription factor AP-2 beta like gene (TFAP2BL1). | Q34104035 | ||
Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen | Q34163571 | ||
Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements | Q34164797 | ||
Patterning Systems—From One End of the Limb to the Other | Q34189919 | ||
Gene regulation in melanoma progression by the AP-2 transcription factor | Q34224140 | ||
Genetics of craniofacial development and malformation | Q34271559 | ||
Comparative and functional analysis of the AP2 promoter indicates that conserved octamer and initiator elements are critical for activity | Q34602256 | ||
The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma | Q34725896 | ||
Transcription factor AP2 and its role in epidermal-specific gene expression | Q37591852 | ||
A long-range regulatory element of Hoxc8 identified by using the pClasper vector | Q37694251 | ||
Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer | Q38466179 | ||
AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression | Q45345486 | ||
Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. | Q46001099 | ||
AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells | Q48063172 | ||
Mechanisms identified in the transcriptional control of epithelial gene expression | Q48067012 | ||
Overexpression of transcription factor AP-2alpha suppresses mammary gland growth and morphogenesis. | Q52107622 | ||
Chicken transcription factor AP-2: cloning, expression and its role in outgrowth of facial prominences and limb buds. | Q52192985 | ||
Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis. | Q52197891 | ||
The 6p deletion syndrome: a new orofacial clefting syndrome and its implications for antenatal screening. | Q53458116 | ||
Transcription Factor Activator Protein-2 Is Required for Continued Luteinizing Hormone-Releasing Hormone Expression in the Forebrain of Developing Mice | Q60444130 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | enhancer | Q913367 |
developmental gene expression regulation | Q70697639 | ||
P304 | page(s) | 194-207 | |
P577 | publication date | 2003-10-01 | |
P1433 | published in | Developmental Dynamics | Q59752 |
P1476 | title | Identification and regulation of tissue‐specific cis‐acting elements associated with the human AP‐2α gene | |
P478 | volume | 228 |
Q90291182 | A functional indel polymorphism rs34396413 in TFAP2A intron-5 significantly increases female encephalocele risk in Han Chinese population |
Q92890314 | An approach to integrating exome sequencing for fetal structural anomalies into clinical practice |
Q30988544 | CREB Inhibits AP-2α Expression to Regulate the Malignant Phenotype of Melanoma |
Q28506671 | Cell autonomous roles for AP-2alpha in lens vesicle separation and maintenance of the lens epithelial cell phenotype |
Q35740259 | Cre-mediated recombination can induce apoptosis in vivo by activating the p53 DNA damage-induced pathway |
Q38017594 | Driving transcriptional regulators in melanoma metastasis |
Q37334244 | Frontal nasal prominence expression driven by Tcfap2a relies on a conserved binding site for STAT proteins |
Q38344570 | Frontonasal process-specific disruption of AP-2alpha results in postnatal midfacial hypoplasia, vascular anomalies, and nasal cavity defects |
Q28654627 | Functional analysis of limb transcriptional enhancers in the mouse |
Q57444461 | Genetic Dissection of a Supergene Implicates in Craniofacial Evolution of Threespine Sticklebacks |
Q28592776 | Identification and analysis of a conserved Tcfap2a intronic enhancer element required for expression in facial and limb bud mesenchyme |
Q21563367 | Mutations in Hedgehog acyltransferase (Hhat) perturb Hedgehog signaling, resulting in severe acrania-holoprosencephaly-agnathia craniofacial defects |
Q34182740 | Neural crest and ectodermal cells intermix in the nasal placode to give rise to GnRH-1 neurons, sensory neurons, and olfactory ensheathing cells |
Q37668700 | Roles of AP-2 transcription factors in the regulation of cartilage and skeletal development |
Q38344566 | Wnt1-Cre-mediated deletion of AP-2alpha causes multiple neural crest-related defects |
Search more.